Real-world duration of maintenance therapy in 2nd-line and later ovarian cancer (OC).

Abstract

e17103Background: Recurrent OC patients may benefit from maintenance therapy, with the goal of inducing a lasting remission or extending the time interval before progression without any deleterious...